InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,408.42
(
-1.73%
)
US TECH 100
17,870.94
(
-3.09%
)
Dow Jones
40,345.41
(
-1.01%
)
Brent Oil
70.89
(
-0.71%
)
Bitcoin
54,352.70
(
0.74%
)
Post# of 14689
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

NYD

Send PM Follow Ignore
Followers 85
Posts 5414
Boards Moderated 0
Alias Born 04/05/2015

NYD

Re: gustavito post# 13660

Wednesday, 03/31/2021 12:55:27 PM

Wednesday, March 31, 2021 12:55:27 PM

Post# of 14689
The PR clearly states the following, "Generex has surpassed the final threshold and has completed its GMP manufacturing of its vaccine for human clinical trials, which is a key necessary component to be included in the company’s IND submission". No doubt, that is huge progress!
Regardless of what happened in the distant past, it appears GNBT is slowly but surely progressing toward something "big time" for it's shareholders. GLTA!
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up